Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
A cancer treatment strategy that involves conjugation of a prodrug-activating enzyme (such as cytosine deaminase, which converts the non-toxic prodrug 5-fluorocytosine to the anticancer drug 5-fluorouracil) to a tumour-targeting antibody
:upscale()/2014/08/05/934/n/1922729/2d5f4c930645a8ba_kimk.jpg)
Preliminary evaluation does not suggest a causal link
1f and Supplementary Fig
Lack of awareness of these common risk factors often leads to delay in seeking preventive or medical care
95% CI, 0.86-0.9) and pneumonia (HR = 0.84
Use this quick filter before spending money or starting anything new: Whats the main barrier right now
US$ 29.28
US$ 21.60
US$ 23.95
US$ 26.91
US$ 29.26
